Scientists from International Academy of Life Sciences, Germany are exploring alternate options for the production of therapeutic proteins. Animal pharming describes the process of using transgenic animals to produce proteins that are used in pharmaceutical production. This process involves the splicing and insertion of a foreign gene into the chromosome of a particular animal.  The protein encoded by the transgenic is secreted into the animal's milk, eggs or blood, and extracted, refined, and used as the active pharmaceutical ingredient (API) in a pharmaceutical application.